|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1B
|
|
pubmed:dateCreated |
2007-3-12
|
|
pubmed:abstractText |
Weekly paclitaxel and infusional high-dose 5-fluorouracil/leucovorin (HDFL) are both effective regimens for metastatic breast cancer (MBC) patients.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
0250-7005
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
27
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
641-5
|
|
pubmed:meshHeading |
pubmed-meshheading:17348454-Adult,
pubmed-meshheading:17348454-Aged,
pubmed-meshheading:17348454-Alopecia,
pubmed-meshheading:17348454-Anemia,
pubmed-meshheading:17348454-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:17348454-Breast Neoplasms,
pubmed-meshheading:17348454-Diarrhea,
pubmed-meshheading:17348454-Dose-Response Relationship, Drug,
pubmed-meshheading:17348454-Drug Administration Schedule,
pubmed-meshheading:17348454-Female,
pubmed-meshheading:17348454-Fluorouracil,
pubmed-meshheading:17348454-Humans,
pubmed-meshheading:17348454-Infusions, Intravenous,
pubmed-meshheading:17348454-Leucovorin,
pubmed-meshheading:17348454-Male,
pubmed-meshheading:17348454-Middle Aged,
pubmed-meshheading:17348454-Nausea,
pubmed-meshheading:17348454-Neoplasm Metastasis,
pubmed-meshheading:17348454-Neutropenia,
pubmed-meshheading:17348454-Paclitaxel,
pubmed-meshheading:17348454-Survival Analysis,
pubmed-meshheading:17348454-Treatment Outcome
|
|
pubmed:articleTitle |
A phase II trial of weekly paclitaxel and high-dose 5-fluorouracil plus leucovorin in patients with chemotherapy-pretreated metastatic breast cancer.
|
|
pubmed:affiliation |
Departments of Oncology, National Taiwan University Hospital, Taipei, Taiwan.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial, Phase II
|
